---
figid: PMC11432004__ijms-25-09896-g003
pmcid: PMC11432004
image_filename: ijms-25-09896-g003.jpg
figure_link: /pmc/articles/PMC11432004/figure/F3/
number: Figure 3
figure_title: Pathways associated with O-GlcNAcylation, thrombosis, inflammation,
  and cancer.
caption: 'Pathways associated with O-GlcNAcylation, thrombosis, inflammation, and
  cancer. Abbreviations: TGFα, transforming growth factor alpha; EGF, epidermal growth
  factor; PDGF, platelet-derived growth factor subunit A; IGF, insulin-like growth
  factor; KITLG, KIT ligand; FLT3LG, fms-related tyrosine kinase 3 ligand; HGF, hepatocyte
  growth factor; FGF, fibroblast growth factor 1; EGFR, epidermal growth factor receptor;
  ERBB2, receptor tyrosine protein kinase erbB-2; PDGFR, platelet-derived growth factor
  receptor alpha; IGFR, insulin-like growth factor 1 receptor; C-KIT, proto-oncogene
  tyrosine protein kinase Kit; FLT3, fms-related tyrosine kinase 3; MET, proto-oncogene
  tyrosine protein kinase Met; FGFR, fibroblast growth factor receptor 1; Grb2, growth
  factor receptor-bound protein 2; Sos, son of sevenless; Ras, GTPase Ras; Raf, A-Raf
  proto-oncogene serine/threonine protein kinase; MEK or MAP2K1, mitogen-activated
  protein kinase kinase 1; ERK, mitogen-activated protein kinase 1/3; c-Myc, Myc proto-oncogene
  protein; c-Fos, proto-oncogene protein c-fos; c-Jun, transcription factor AP-1;
  VEGF, vascular endothelial growth factor; MMPs, matrix metalloproteinases (interstitial
  collagenase); IL-8, interleukin 8; CyclinD1, G1/S-specific cyclin-D1; CDK4, cyclin-dependent
  kinase 4; PLCγ, phosphatidylinositol phospholipase C, gamma-1; DAG, diacylglycerol;
  IP3, inositol 1,4,5-trisphosphate; Ca2+, calcium 2+; PKC, classical protein kinase
  C; CAM, calmodulin; CAMK, calcium/calmodulin-dependent protein kinase (CaM kinase)
  II; Elk, ETS domain-containing protein Elk-1; PTEN, phosphatidylinositol-3,4,5-trisphosphate
  3-phosphatase and dual-specificity protein phosphatase PTEN; PI3K, phosphatidylinositol-4,5-bisphosphate
  3-kinase catalytic subunit alpha/beta/delta; Akt, RAC serine/threonine protein kinase;
  mTOR, serine/threonine protein kinase mTOR; S6K, ribosomal protein S6 kinase beta;
  IKK, inhibitor of nuclear factor kappa-B kinase; Iκβα, NF-kappa-B inhibitor alpha;
  NFκβ, nuclear factor NF-kappa-B p105 subunit; COX-2, prostaglandin endoperoxide
  synthase 2; iNOS, nitric oxide synthase, inducible'
article_title: 'O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer'
citation: Itzel Patricia Vásquez Martínez, et al. Int J Mol Sci. 2024 Sep;25(18).
year: '2024'
pub_date: 2024-9-
epub_date: 2024-9-13
doi: 10.3390/ijms25189896
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords:
- O-GlcNAc
- hemostasis
- inflammation
- cancer
- post-translational modification
---
